Actively Recruiting
Study of the Effect of Peripheral Somatosensory Stimulation on the Functionality of Patients With Cerebral Palsy and Reduced Mobility
Led by Facultat de ciencies de la Salut Universitat Ramon Llull · Updated on 2025-04-30
20
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
Sponsors
F
Facultat de ciencies de la Salut Universitat Ramon Llull
Lead Sponsor
C
Cerebral Palsy Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cerebral palsy (CP) is a permanent neurological disorder that affects movement and posture, caused by an injury to the developing brain. It may also be accompanied by cognitive, hearing, and speech impairments, as well as epilepsy. Although it is a condition that manifests in childhood, its effects persist throughout life, posing specific challenges in mobility and functionality during adulthood. Although physiotherapy is a key component in the rehabilitation of children with CP and helps adults manage pain and improve motor function, many adults with CP do not receive the treatment they need. Barriers such as financial difficulties, transportation issues, and the lack of physiotherapists specialized in CP affect both access to and the quality of care. Even when physiotherapy is provided, adults with CP are often less satisfied with the services compared to children.The aim of this study is to promote the recovery of motor function in adults with cerebral palsy through sensory stimulation of the lower limbs, as part of an intensive motor rehabilitation program. This program seeks to foster autonomy in movements and transfers, as well as active participation in daily life activities.
CONDITIONS
Official Title
Study of the Effect of Peripheral Somatosensory Stimulation on the Functionality of Patients With Cerebral Palsy and Reduced Mobility
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults with a medical diagnosis of cerebral palsy
- Age between 18 and 50 years
- Reduced mobility classified as levels I, II, or III according to the GMFCS
- Ability to participate in functional assessments with support from the clinical team
- Ability to understand informed consent or have a legal representative provide consent
You will not qualify if you...
- Severe cognitive impairments that prevent understanding instructions or participating in assessments
- Medical conditions interfering with the intervention, such as severe cardiovascular disease or major neurological disorders
- Participation in another intervention study during the same period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pedro Victor López Plaza
Barcelona, Spain
Actively Recruiting
Research Team
P
Pedro V López Plaza, Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here